# Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea

> **NCT06690723** · PHASE3 · COMPLETED · sponsor: **University Malaysia Sarawak** · enrollment: 160 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Dapagliflozin (Forxiga)
- **DRUG:** Vitamin D3 ( Colecalciferol)
- **DRUG:** Vitamin D3 plus Dapagliflozin
- **BEHAVIORAL:** Lifestyle modification

## Key facts

- **NCT ID:** NCT06690723
- **Lead sponsor:** University Malaysia Sarawak
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-08
- **Primary completion:** 2024-09-03
- **Final completion:** 2024-09-03
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06690723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06690723, "Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06690723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*